Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs - PubMed (original) (raw)
. 1990 Jun;14(6):495-503.
Affiliations
- PMID: 2401586
Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs
R R Wing et al. Int J Obes. 1990 Jun.
Abstract
Because weight loss is difficult to achieve, it would be helpful to determine whether there are subgroups of obese type II diabetic patients who benefit most from participation in a behavioral weight loss program. We studied 178 obese patients with type II diabetes, who participated in a 12-20 week behavioral weight loss program and were followed for 1 year after the program to determine whether age, gender, percent overweight, medication, duration of diabetes or fasting glucose were related to weight loss and/or to the magnitude of improvement in glycemic control experienced with weight loss. Gender was the only variable related to weight loss; males lost more weight and had greater decreases in percent overweight than females. The variable most strongly related to improvement in glycemic control was pretreatment fasting glucose level; patients with higher initial glucose levels experienced the greatest improvements in control. There was no evidence to support the belief that patients on insulin have poorer weight losses or that patients with long-duration diabetes benefit less from weight reduction than those with recent-onset diabetes.
Similar articles
- Long-term effects of modest weight loss in type II diabetic patients.
Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Wing RR, et al. Arch Intern Med. 1987 Oct;147(10):1749-53. Arch Intern Med. 1987. PMID: 3310940 - The effect of weight loss on change in waist-to-hip ratio in patients with type II diabetes.
Pascale RW, Wing RR, Blair EH, Harvey JR, Guare JC. Pascale RW, et al. Int J Obes Relat Metab Disord. 1992 Jan;16(1):59-65. Int J Obes Relat Metab Disord. 1992. PMID: 1314245 - Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects.
Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH. Wing RR, et al. Arch Intern Med. 1991 Jul;151(7):1334-40. Arch Intern Med. 1991. PMID: 2064484 Clinical Trial. - [Very-low-calorie-diets: is there a place for them in the management of the obese diabetic?].
Monnier L, Colette C, Percheron C, Boniface H. Monnier L, et al. Diabetes Metab. 2000 Jun;26 Suppl 3:46-51. Diabetes Metab. 2000. PMID: 10945153 Review. French. - Dietary treatment and long-term weight loss and maintenance in type 2 diabetes.
Hensrud DD. Hensrud DD. Obes Res. 2001 Nov;9 Suppl 4:348S-353S. doi: 10.1038/oby.2001.141. Obes Res. 2001. PMID: 11707564 Review.
Cited by
- Bariatric Surgery: Pathophysiology and Outcomes.
Azim S, Kashyap SR. Azim S, et al. Endocrinol Metab Clin North Am. 2016 Dec;45(4):905-921. doi: 10.1016/j.ecl.2016.06.011. Epub 2016 Oct 8. Endocrinol Metab Clin North Am. 2016. PMID: 27823611 Free PMC article. Review. - Orlistat in the prevention of diabetes in the obese patient.
Mancini MC, Halpern A. Mancini MC, et al. Vasc Health Risk Manag. 2008;4(2):325-36. doi: 10.2147/vhrm.s6808. Vasc Health Risk Manag. 2008. PMID: 18561508 Free PMC article. Review.